Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Terminated 1Recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2Gynecologic 1Breast 1

Conditions

Breast Neoplasms 28Neoplasm Metastasis 9Neoplasms 8Brain Neoplasms 5Ovarian Neoplasms 4Triple Negative Breast Neoplasms 3Recurrence 3Prostatic Neoplasms 3Neoplasms by Site 3Glioma 3Endometrial Neoplasms 3Breast Diseases 3Squamous Cell Carcinoma of Head and Neck 2Liposarcoma 2Head and Neck Neoplasms 2Uterine Cervical Neoplasms 1Unilateral Breast Neoplasms 1Spinal Cord Neoplasms 1Small Cell Lung Carcinoma 1Sarcoma, Kaposi 1Sarcoma, Ewing 1Sarcoma 1Recurrent Ovarian High Grade Serous Adenocarcinoma 1Pathologic Complete Response 1Pancreatic Neoplasms 1Neurofibromatosis 1 1Neoplasms, Squamous Cell 1Multiple Myeloma 1Meningioma 1Lymphoma, Non-Hodgkin 1

Interventions

pembrolizumab 60Cisplatin 43Cetuximab 25Carboplatin 24Paclitaxel 19Radiotherapy, Intensity-Modulated 18Magnetic Resonance Spectroscopy 18Nivolumab 17Radiotherapy 16Specimen Handling 14Docetaxel 13Platinum 121,2-diaminocyclohexaneplatinum II citrate 11Taxes 8Fluorouracil 8Biopsy 7atezolizumab 6Radiation 6(225)Ac-DOTA-c(RGDyK) 6dostarlimab 5cemiplimab 5Ipilimumab 5Standard of Care 4Immunoglobulin G 4Disulfides 4Cyclophosphamide 4Bevacizumab 4Albumin-Bound Paclitaxel 4130-nm albumin-bound paclitaxel 4toripalimab 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Squamous Cell Carcinoma of Head and Neck × abemaciclib × 90 days × Clear all
NCT05768139 2026-06-04

PIKALO-1

Eli Lilly and Company

Phase 1/2 Recruiting
880 enrolled
BreastGynecologicHead & Neck

Squamous Cell Carcinoma of Head and Neck, Breast Diseases, Breast Neoplasms, Uterine Cervical Neoplasms, Head and Neck Neoplasms, Neoplasms, Neoplasms by Site, Hereditary Sensory and Autonomic Neuropathies, Ovarian Neoplasms, Endometrial Neoplasms

NCT04169074 2026-05-22

Immune Modulation by Abemaciclib in Head and Neck Squamous Cell Carcinoma (HNSCC). (AIM Trial)

University of Arizona

Phase 2 Terminated
7 enrolled 14 charts
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Neoplasms, Squamous Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡